Eli Lilly Commits $1B to Get Drug That Could Rival Vertex’s New Non-Opioid Pain Med
Eli Lilly is expanding its pain drug pipeline with the acquisition of SiteOne Therapeutics, a startup whose lead program addresses the same target as a Vertex Pharmaceuticals product ...